2020
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
Britain
|
|
Russia
|
|
USA
|
|
China
|
Detailed explanation-1: -The EpiVacCorona vaccine contributes to the development of protective immunity against SARS-CoV-2 coronavirus following two intramuscular administrations given 21 to 28 days apart. 750 volunteers who will be vaccinated with a placebo, twice intramuscularly at a dose of 0.5 ml.
Detailed explanation-2: -EpiVacCorona (Russian: , tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the VECTOR center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media.
Detailed explanation-3: -The EpiVacCorona vaccine relies on chemically synthesized peptide antigens of SARS-CoV-2 proteins, conjugated to a carrier protein and adsorbed on an aluminum-containing adjuvant (aluminum hydroxide). The vaccine does not contain the live virus and forms immunity due to artificially synthesized peptides.
Detailed explanation-4: -Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).